SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
1.851
-0.026 (-1.40%)
May 14, 2025, 12:51 PM - Market open
SAB Biotherapeutics Market Cap
SAB Biotherapeutics has a market cap or net worth of $17.19 million as of May 14, 2025. Its market cap has decreased by -56.15% in one year.
Market Cap
17.19M
Enterprise Value
11.35M
1-Year Change
-56.15%
Ranking
Category
Stock Price
$1.85
Market Cap Chart
Since February 9, 2021, SAB Biotherapeutics's market cap has decreased from $130.75M to $17.19M, a decrease of -86.85%. That is a compound annual growth rate of -37.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 17.44M | -50.21% |
| Dec 31, 2024 | 35.02M | -44.79% |
| Dec 29, 2023 | 63.43M | 113.36% |
| Dec 30, 2022 | 29.73M | -91.24% |
| Dec 31, 2021 | 339.54M | 159.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 645.94B |
| Johnson & Johnson | 351.94B |
| AbbVie | 317.95B |
| Novo Nordisk | 288.64B |
| UnitedHealth Group | 283.03B |
| Abbott Laboratories | 223.80B |
| Novartis AG | 209.81B |
| AstraZeneca | 209.59B |